SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
杏子
Lv3
350 积分
2023-10-01 加入
最近求助
最近应助
互助留言
Prognostic value ofKRASmutations,TP53mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
9天前
已完结
Risk of second primary malignancy after non-small cell lung cancer: a competing risk nomogram based on the SEER database
11天前
已完结
Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis
11天前
已完结
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study
28天前
已完结
A nomogram model for predicting the risk of checkpoint inhibitor‐related pneumonitis for patients with advanced non‐small‐cell lung cancer
28天前
已完结
Combined influence of nutritional and inflammatory status and depressive symptoms on mortality among US cancer survivors: Findings from the NHANES
30天前
已完结
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival
1个月前
已完结
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis
2个月前
已完结
RATIONALE-309: Updated progression-free survival (PFS), PFS after next line of treatment, and overall survival from a phase 3 double-blind trial of tislelizumab versus placebo, plus chemotherapy, as first-line treatment for recurrent/metastatic nasopharyngeal cancer
2个月前
已关闭
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
2个月前
已完结
没有进行任何应助
速度真快
9天前
点赞
11天前
速度真快
11天前
速度真快,帮大忙了
27天前
速度真快
28天前
速度真快
30天前
速度真快
1个月前
点赞
2个月前
速度真快
2个月前
点赞
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论